TipRanks
Akari Therapeutics (DE:CLA1)
FRANKFURT:CLA1

Compare Akari Therapeutics (CLA1) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Akari Therapeutics
€0.06
€13.10M
>-0.01
-99.82%
3 Buy
0 Hold
0 Sell
Strong Buy
NanoViricides
$1.28
$35.73M
-3.49
-8.39%
1 Buy
0 Hold
0 Sell
Moderate Buy
Moleculin Biotech
$0.61
$9.08M
-0.03
-96.66%
3 Buy
0 Hold
0 Sell
Strong Buy
Passage Bio
$4.52
$13.13M
-0.34
-54.35%
0 Buy
1 Hold
0 Sell
Hold
SAB Biotherapeutics
$3.88
$266.59M
0.81
23.50%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:CLA1
Akari Therapeutics
0.06
-31.74
-99.81%
SONN
―
―
―
―
NNVC
NanoViricides
1.31
-0.11
-8.07%
MBRX
Moleculin Biotech
0.42
-12.48
-96.71%
PASG
Passage Bio
3.78
-4.90
-56.45%
SABS
SAB Biotherapeutics
2.89
0.39
15.60%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts